Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis

September 9, 2023 updated by: Zeeshan Qamar, Riyadh Elm University

For proving the potential of tropical medicaments on clinical parameters of periodontitis, a comprehensive assessment is required between therapeutic medicaments. The main aim of the study was to clinically evaluate and compare the efficacy of indocyanine green mediated photodynamic therapy (PDT) and aleo vera (AV) extract when used as an adjunct therapy to scaling and root planning (SRP) for treatment of chronic periodontitis.

One hundred and fifty patients included in this study were randomly distributed in three treatment groups Group I (SRP), Group II (SRP+PDT) and Group III (SRP+AV). Four clinical parameters plaque index (PI), bleeding on probing (BoP), periodontal (PD) pocket depth and clinical attachment level (CAL) were evaluated at three time points baseline, 3rd and 6th month respectively. Additionally the amount of three inflammatory cytokines IL-6, IL-8 and TNF- α in gingival crevicular fluid (GCF) was identified using enzyme linked immune-sorbent assay (ELISA) technique.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Karachi, Pakistan
        • Liaquat College of Medicine and Dentistry
      • Riyadh, Saudi Arabia
        • Riyadh Elm University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age of ≥ 30 years;
  • ≥ 20 natural teeth; and
  • chronic-periodontitis (≥ 3 mm of CAL and PD pocket depth respectively on at least 30% of dental sites).

Exclusion Criteria:

  • chronic systemic diseases;
  • PD therapy during last 6 months;
  • habitual use of chewable and non-chewable tobacco (smoking);
  • alcohol consumers; or
  • use of particular medications during last three months (steroidal and non-steroidal drugs/ anti-biotic/ anti-depressants)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group I (Standard Root Planning)
Natural plant extract
Other Names:
  • Aloe Vera
Active Comparator: Group II (Standard Root Planning + Photodynamic Therapy)
Natural plant extract
Other Names:
  • Aloe Vera
Experimental: Group III (Standard Root Planning + Aloe Vera)
Natural plant extract
Other Names:
  • Aloe Vera

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinically Evaluating the Effects of Topical Indocyanine-green Mediated Photosensitizer VS Aloe vera Gel: Adjunct therapy to Scaling and Root Planing in Patients with Chronic Periodontitis
Time Frame: 9 months
Adjunct treatment regimens PDT and AV extract significantly helped in plummeting inflammation of PD tissue
9 months
IL-6 concentration in pg/ml
Time Frame: 6 months
Identify the concentration of IL-6 in the gingival crevicular fluid
6 months
IL-8 concentration in pg/ml
Time Frame: 6 months
Identify the concentration of IL-8 in the gingival crevicular fluid
6 months
TNF-α levels in pg/ml
Time Frame: 6 months
Identify the concentration of TNF-α in the gingival crevicular fluid
6 months
Periodontal pocket depth in mm
Time Frame: 6 months
Periodontal pocket depth
6 months
Clinical attachment loss in mm
Time Frame: 6 months
Periodontal attachment loss
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 7, 2021

Primary Completion (Actual)

February 28, 2022

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

June 28, 2021

First Submitted That Met QC Criteria

July 13, 2021

First Posted (Actual)

July 15, 2021

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 9, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Plant extract

Subscribe